Surveillance and Screening During Disease-Free Survival
After surgery for cancer of the spine, follow-up care to detect recurrence is an expected part of the overall postoperative care. Components of disease-free surveillance include periodic physical examinations, radiological studies, and blood work to follow or detect tumor markers. Establishing standards for routine follow-up may be difficult owing to the variability of cancers involving the spine (low-grade sarcomas, high-grade sarcomas, and metastatic disease) and the extent of involvement throughout the spine or body.
KeywordsBreast Cancer Clin Oncol Clinical Oncology Clinical Practice Guideline Cancer Surveillance
Unable to display preview. Download preview PDF.
- 3.Winn RJ. The role of oncology clinical practice guidelines in the managed care era. Oncology (Huntingt) 1995; 9:177–183.Google Scholar
- 5.Smith TJ, Somerfield MR. The ASCO experience with evidence-based clinical practice guidelines. Oncology (Huntingt) 1997; 11:223–227.Google Scholar
- 6.American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 1997; 15:2149–2156.Google Scholar
- 12.American Society of Clinical Oncology. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1998; 16:793–795.Google Scholar
- 15.Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001—testing for early lung cancer detection. CA Cancer J Clin 2001; 51:38–75.PubMedCrossRefGoogle Scholar
- 16.American Society of Clinical Oncology. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996; 14:2843–2877.Google Scholar
- 21.American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997; 15:2996–3018.Google Scholar